Advertisement

Topics

Corbus Reports Positive Topline Results from Phase II Study in Rare Autoimmune Disease Dermatomyositis

15:00 EDT 24 Oct 2017 | Drug Discovery Development

News
Related Biotechnology, Pharmaceutical and Healthcare News
Anabasum was well tolerated with no severe or serious side effects associated with the drug.
Contributed Author: 
Corbus Pharmaceuticals
Topics: 
Clinical Trials

Original Article: Corbus Reports Positive Topline Results from Phase II Study in Rare Autoimmune Disease Dermatomyositis

NEXT ARTICLE

More From BioPortfolio on "Corbus Reports Positive Topline Results from Phase II Study in Rare Autoimmune Disease Dermatomyositis"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.